This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by André, N. Articles by Briand, C. Search for Related Content PubMed PubMed Citation Articles by André, N. Articles by Briand, C.

Paclitaxel Induces Release of Cytochrome c from Mitochondria Isolated from Human Neuroblastoma Cells¹

UPRESA Centre National de la Recherche Scientifique 6032, Universite de la Mediterranée, Faculty of Pharmacy, 13005 Marseille, France [N. A., D. B., A. G., S. G., C. B.]; Department of Proteins, Bioenergetics, and Engineering, Centre National de la Recherche Scientifique, 13402 Marseille Cedex 20, France [G. B., D. L-M.]; Department of Pediatric Oncology, Children’s Hospital of La Timone,13005 Marseille, France [N. A.]; and Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, California 93106-9610 [M. A. J.]

	ABSTRACT

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

 
Paclitaxel is an antimicrotubule agent that induces mitotic block and apoptosis. We show for the first time that paclitaxel acts directly on mitochondria isolated from human cancer cells. In isolated yeast mitochondria, paclitaxel (15 µM) induced an 18% increase in the respiration rate, with no concomitant release of cytochrome c. In isolated neuroblastoma mitochondria, paclitaxel (10–100 µM) induced a 27–72% release of cytochrome c. Release was prevented by cyclosporin A, suggesting the involvement of the permeability transition pore. Doxorubicin did not induce cytochrome c release, whereas vinorelbine, another antimicrotubule agent, did. Thus, antimicrotubule agents can directly affect mitochondria to induce apoptosis.

	Introduction

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

 
For years, the known function of mitochondria was limited to energy production through a process in which electrons are transferred along a series of respiratory enzyme complexes. This electron transfer is coupled to proton translocation on the positive side of the membrane, and the resulting electrochemical gradient is used to synthesize ATP by ATP synthase (1) . It has recently been found that mitochondria can also regulate and promote apoptosis by releasing cytochrome c from the mitochondrial intermembrane space into the cell cytosol (2, 3, 4) . How cytochrome c is released by mitochondria is still unclear (5) . The main hypothesis is that the transient or sustained opening of the PTP,³ a multiprotein complex formed at the contact site between the inner and the outer mitochondrial membranes, allows the release of cytochrome c with or without mitochondrial swelling. Cytochrome c release may also occur by changes in the permeability of the mitochondrial outer membrane, partially in response to Bcl-2 family proteins (5 , 6) . Paclitaxel (Taxol), an anticancer drug that is highly efficacious in the treatment of several malignancies (7) , is an antimicrotubule agent that stabilizes the microtubule network and inhibits the dynamics of microtubules (8) . Paclitaxel induces apoptosis after G₂-M-phase blockage and Bcl-2 phosphorylation, but the mechanisms of paclitaxel-induced apoptosis remain controversial (9) . We have previously shown that mitochondrial transition permeability was modified simultaneously with activation of caspase-8 and caspase-3 during apoptosis induced by paclitaxel in proliferating cells (10) . Moreover, mitochondria are involved in neuroblastoma cell apoptosis mediated by anticancer agents (11) . However, few studies have investigated the direct effects of anticancer agents on isolated mitochondria (12, 13, 14, 15) . In the present study, we tested the effects of paclitaxel, vinorelbine, and doxorubicin on mitochondria isolated from yeast and human neuroblastoma cancer cells in a cell-free system. We have previously reported that these three drugs induce apoptosis in neuroblastoma SK-N-SH cells (16) . Here we present the first evidence that antimicrotubule agents, but not doxorubicin, have a direct effect on mitochondria isolated from both yeast Saccharomyces cerevisiae, in which they induce an increase in respiration, and neuroblastoma cells, in which they induce the release of cytochrome c.

	Materials and Methods

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

 
Drugs.
Stock solutions of paclitaxel (Sigma, St. Louis, MO) and CsA (Sigma) were prepared in DMSO. Stock solutions of vinorelbine (Pierre Fabre Oncologie, Paris, France) and doxorubicin (Dakota, Créteil, France) were prepared in water. Stock solutions were stored at -20°C, with the exception of CsA and vinorelbine solutions, which were stored at 4°C. The highest final DMSO concentration used was 0.2%.

Yeast and Cell Culture.
Yeast strain KM-91 was cultured as described previously (17) . Human neuroblastoma SK-N-SH cells were cultured in RPMI 1640 (16) .

Isolation of Mitochondria.
Yeast mitochondria were prepared as described previously (17) . Mitochondria were isolated from neuroblastoma cells as follows (18) . Briefly, 3 x 10⁷ SK-N-SH cells were trypsinized and washed with ice-cold PBS. The cell pellet was suspended in buffer A (250 mM sucrose, 20 mM HEPES, 1 mM DTT, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1.5 mM MgCl₂, phenylmethylsulfonyl fluoride, and protease inhibitors) at 4°C. Cells were homogenized with 45 strokes in a glass homogenizer (Kontes, Vineland, NJ) and centrifuged at 800 x g for 10 min to remove unbroken cells and nuclei. Mitochondria were then pelleted by centrifugation at 15,000 x g for 10 min at 4°C. The mitochondrial pellet was rinsed twice in buffer A and immediately resuspended, aliquoted, and incubated with drugs as indicated.

Measurement of RR in Yeast Mitochondria.
KM-91 yeast mitochondria (1.5 mg) were suspended in respiration buffer with a range of concentrations of paclitaxel (15–225 µM) and incubated for 40–120 min at 25°C. NADH (3 mM) and succinate (50 mM) were used as substrates to initiate respiration, and the rate was measured using a Clark oxygen electrode (17) . The RR equals the slope of oxygen consumption over time.

Incubation of Isolated Mitochondria with Drugs.
Neuroblastoma cell mitochondria were incubated for 2 h in buffer A at 37°C with CsA (2 µM), a range of concentrations of paclitaxel (10, 50, and 100 µM), doxorubicin (50 µM), vinorelbine (20 µM), and paclitaxel (50 µM) or vinorelbine (20 µM) after a 2-min preincubation with CsA (2 µM). Isolated yeast mitochondria were incubated (0.5–4 h) with a range of paclitaxel concentrations (20–100 µM) at temperatures ranging from 25°C to 30°C. Equivalent amounts of DMSO were added to control samples.

Western Blot Analysis of Cytochrome c from Mitochondria Isolated from Neuroblastoma Cells.
After centrifugation (10 min, 15,000 x g) of treated mitochondria, supernatants were removed carefully. Pellets were lysed in buffer B [2 mM EDTA, 100 mM NaCl, 1 mM orthovanadate, 1% Triton X-100, and 50 mM Tris (pH 7.5)], loaded on a 15% SDS polyacrylamide gel, transferred to a nitrocellulose membrane, and incubated with cytochrome c monoclonal antibody (7h82C12; PharMingen, San Diego, CA) and an antimouse monoclonal antibody conjugated with peroxidase. Visualization and densitometric quantitation were performed using enhanced chemiluminescence (Amersham, Aylesbury, United Kingdom) and Traitima, an in-house densitometric software in Visual BASIC for Windows 95 (19) . Briefly, the gel images were digitized, and the gray level of the pixels was used to calculate the area of each spot and to plot the intensity curves. A monoclonal antibody against VDAC (529534; Calbiochem, La Jolla, CA), a major component of mitochondrial membranes (20) , was used to ensure that equal amounts of mitochondrial proteins were loaded onto the gel and that no mitochondrial protein remained in the supernatant. -Tubulin antibody (N356; Amersham) was used to demonstrate the presence of tubulin in mitochondrial membranes and the absence of contamination of mitochondrial preparations.

Transmission Electron Microscopy.
Aliquots of isolated mitochondria were treated with 100 µM paclitaxel or 0.2% DMSO for 2 h at 37°C, fixed in 4% glutaraldehyde, dehydrated in ethanol, embedded in Epon, and cut into thin sections (19) . The samples were imaged by a transmission electron microscope (JEOL 100C). The longest diameter of all mitochondria in a given area was measured on printed photographs. Statistical analysis was performed using Student’s t test.

	Results

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

 
Paclitaxel Induced an Increase in the RR of Mitochondria Isolated from Yeast.
Paclitaxel (15 µM) induced a significant increase (18 ± 9%) in the RR of isolated yeast mitochondria (P < 0.001; Fig. 1A ). No increase was observed at lower paclitaxel concentrations, and increasing the paclitaxel concentration to a level as high as 225 µM induced no greater effect (Fig. 1B) . A minimum of 0.5 h of incubation was required to observe the increase. Paclitaxel induced the same increase regardless of whether NADH, succinate (substrate for complex I and II of the respiration chain, respectively), or both were tested. The uncoupler carbonyl cyanide m-chlorophenylhydrazone (25 µM) induced an additional increase in the RR even after paclitaxel treatment (data not shown). Thus, paclitaxel increased the RR by acting directly on isolated yeast mitochondria.

View larger version (24K): [in this window] [in a new window]   Fig. 1. Paclitaxel (Px) induced an increase in the RR but not in the release of cytochrome c from isolated yeast mitochondria. A, RR of mitochondria treated for 2 h with 15 µM paclitaxel in medium containing 0.65 M sorbitol, 10 mM KH2PO4, 2 mM EDTA, 0.1 mM MgCl2, and 0.3% BSA (pH 6.5) was measured with a Clark oxygen electrode. The arrow represents the addition of mitochondrial substrates (S) [NADH (3 mM) and succinate (50 mM)] that initiate mitochondrial respiration. RR equals the slope of oxygen consumption over time. One experiment representative of four independent experiments is shown. B, increase in RR induced by paclitaxel; data are the mean ± SD of four independent experiments, measured as described in A. C, Western blot analysis of cytochrome c in mitochondrial pellet and supernatant after paclitaxel treatment (100 µM) for 2 and 4 h.

Paclitaxel Induced the Release of Cytochrome c from Mitochondria Isolated from Neuroblastoma Cells.
Mitochondria were successfully isolated from SK-N-SH cells as measured by Western blots of VDAC, an outer mitochondrial membrane protein, and tubulin (Fig. 2A) . VDAC was present at the same level in the mitochondrial pellets but was absent in the supernatants of all of the samples. The mitochondrial pellets contained a significant amount of tubulin (Fig. 2 A right panel) that appears to be in the mitochondria and not simply a contaminant of the pellets. Pelleted tubulin did not appear to be a contaminant for several reasons. First, it did not appear in the supernatants and thus is not soluble. Secondly, microtubules were not pelleted under the conditions for isolating mitochondria (4°C, 15,000 x g, 10 min) because no microtubules were observed by transmission electron microscopy of the paclitaxel-treated samples (data not shown). Thus, immunodetection of tubulin in mitochondrial pellets confirms the presence of tubulin in mitochondria (21) .

View larger version (57K): [in this window] [in a new window]   Fig. 2. Antimicrotubule agents induce the release of cytochrome c (Cytc) from isolated neuroblastoma mitochondria in a CsA-sensitive way. A, mitochondrial pellets and their respective supernatants were analyzed by immunoblotting using a cytochrome c monoclonal antibody. A monoclonal antibody to VDAC was used to ensure that the quantity of mitochondrial protein was the same in each lane and that there was no contamination of supernatants by mitochondria. Lane 2 (control), 0.2% DMSO was added (the same quantity was used in Lane 6). Lane 4, mitochondria were pretreated with CsA before paclitaxel treatment to study the involvement of PTP. Lanes 5–7, mitochondria were incubated with increasing concentrations of paclitaxel (Px; 10–100 µM). Lanes 8 and 9, immunoblotting with a tubulin monoclonal antibody indicated the presence of tubulin in the control and paclitaxel-treated mitochondrial pellets and also indicated that there was no soluble tubulin in the mitochondrial preparations released into the supernatants. B, quantitation of cytochrome c levels in the pellets and the supernatants of A represented as the relative intensity of the bands ("Materials and Methods"). Mean ± SD of at least three experiments is shown. C, mitochondria were treated with vinorelbine (VNB) and doxorubicin (DOXO) under the same conditions described in A. In Lane 2, cytochrome c release was completely inhibited by pretreatment with CsA before the addition of vinorelbine.

To examine how cytochrome c was released, we pretreated mitochondria isolated from neuroblastoma cells with CsA, a compound known to inhibit PTP opening. After preincubation with CsA, the release of cytochrome c was inhibited (Fig. 2A) . Thus, paclitaxel induced the release of cytochrome c from mitochondria isolated from SK-N-SH neuroblastoma cells in a CsA-sensitive manner, suggesting the involvement of PTP.

Effects of Doxorubicin and Vinorelbine on Cytochrome c Release from Mitochondria Isolated from Neuroblastoma Cells.
Because paclitaxel induced translocation of cytochrome c by acting directly on mitochondria, we investigated whether this novel property was shared by other antimicrotubule agents or by doxorubicin, a drug whose mechanism of action is independent of microtubules. Interestingly, doxorubicin (50 µM) had no effect on the cytochrome c release from neuroblastoma mitochondria, but vinorelbine (20 µM), an antimicrotubule agent that depolymerizes microtubules, did induce cytochrome c release from mitochondria in a CsA-sensitive way (Fig. 2C) .

Mitochondrial Swelling after Paclitaxel Treatment in Vitro.
Swelling is an important feature of apoptotic mitochondria (5) . Thus, we wanted to know whether the PTP-dependent release of cytochrome c from neuroblastoma mitochondria induced by paclitaxel was associated with mitochondrial swelling. Mitochondria isolated from neuroblastoma cells were treated with paclitaxel under the conditions that induced cytochrome c release and were examined by transmission electron microscopy (Fig. 3, A and B) . The mean diameter of paclitaxel-treated mitochondria (1.2 ± 0.05 µm) was significantly greater than that of control mitochondria (1.0 ± 0.04 µm; P < 0.05; Fig. 3C ), suggesting that the PTP opening resulted in significant swelling and thus was sustained and not merely transient.

View larger version (76K): [in this window] [in a new window]   Fig. 3. Swelling of mitochondria isolated from SK-N-SH neuroblastoma cells after paclitaxel treatment observed with transmission electron microscopy. A, control mitochondria treated for 2 h at 37°C with the same amount of DMSO as used in B (0.2%). B, mitochondria treated with 100 µM paclitaxel under the same experimental conditions described in A. Bars, 500 nm. C, histogram of diameters of control or paclitaxel-treated mitochondria.

	Discussion

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

Paclitaxel concentrations required to induce the release of cytochrome c from isolated mitochondria are higher than those usually used to induce apoptosis in cultured cells. However, paclitaxel accumulates in cells. For example, Jordan et al. (22) found that addition of 10 or 100 nM paclitaxel to HeLa cells resulted in an intracellular paclitaxel concentration of 4.8 and 40.5 µM, respectively. Thus, the intracellular concentration of paclitaxel can reach 500 times the extracellular concentration. Because 1 µM paclitaxel is necessary to induce apoptosis in SK-N-SH cells (16) , the concentrations that we used with isolated mitochondria may reflect the intracellular concentrations that induce apoptosis.

Paclitaxel had direct effects on both yeast and neuroblastoma mitochondria, but the responses were different. In yeast mitochondria, paclitaxel triggered an increase of respiration but no translocation of cytochrome c. This may be due in part to differences between the structure of the PTP in mammalian cells and the unselective channel in yeast mitochondria. Indeed, the unselective channel of yeast mitochondria is not a clear counterpart to PTP because it is neither induced by Ca²⁺ nor inhibited by CsA (23) . Previous studies have shown that paclitaxel could induce changes in respiration (24) and in the PTP conformation (25) , although the release of cytochrome c was not investigated. In contrast to the results reported here, the study by Manzano et al. (24) found a decrease in respiration in mitochondria isolated from rat liver. This difference may have at least two possible explanations. The first is that only one very high paclitaxel concentration (250 µM) was used, and the second is the differing sources of the mitochondria (rat liver as opposed to human cancer cells). The quantity of Bcl-2 family proteins in the mitochondrial membranes may differ, depending on the tissue and the species origin of the mitochondria. Finally, mitochondria in malignant cells may differ from mitochondria in nontumor cells and thus may respond differently to the same apoptotic signal.

Two additional antitumor drugs were tested, vinorelbine and doxorubicin. Interestingly, vinorelbine, a depolymerizing antimicrotubule agent, also induced the release of cytochrome c in a CsA-sensitive manner, whereas doxorubicin, whose mechanism of action is independent of microtubules, had no effect at a concentration of 50 µM. Doxorubicin did not release cytochrome c even at concentrations 100 times higher than the extracellular concentration inducing apoptosis in SK-N-SH cells (16) . Paclitaxel and vinorelbine both bind to tubulin in microtubules but bind to different sites on the tubulin molecule (8) . Thus the direct mitochondrial effect of paclitaxel and vinorelbine may be a phenomenon shared by many antimicrotubule agents. Moreover, evidence suggests that lonidamine and arsenic, compounds that can induce apoptosis by acting directly on mitochondria, may also act on the microtubule network (26 , 27) . Thus, antimicrotubule and antimitochondrial agents may be able to perturb mitochondrial and microtubule physiology as a result of a common target or a common intermediate actor and thus cooperate to induce apoptosis. Bim, a BH3-only protein proapoptotic member of Bcl-2 family (28) , calcium (29) , and tubulin (25) are possible candidates for effectors of the microtubule-mitochondria interrelationship during apoptosis.

How paclitaxel induces the opening of PTP is not known. Our results confirm that tubulin is present on mitochondrial membranes as reported previously (21) , but it is not yet known whether the tubulin is polymerized (which would enhance the binding of paclitaxel to mitochondria). Nevertheless, when present in the mitochondrial membranes, tubulin could adopt a conformation similar to its conformation in the microtubule. Paclitaxel may also interact with Bcl-2 (30) to mediate changes in PTP. The real impact of the direct mitochondrial effect of paclitaxel on apoptosis must be further investigated. The release of cytochrome c in a cell-free system as a result of a direct effect of paclitaxel on mitochondria might explain how paclitaxel could induce apoptosis without mitosis and phosphorylation of Bcl-2 (9) .

Finally, we have demonstrated that antimicrotubule agents are the first widely used family of anticancer agents that act directly on mitochondria. Such an effect has also been reported with some new anticancer agents (lonidamine, arsenite compounds, retinoic acids, and betulinic acid; Refs. 12, 13, 14, 15 ). Altogether, these data suggest that (a) mitochondria may be a new target for anticancer agents, and thus antimitochondrial agents may represent a new class of anticancer agents; and (b) antimicrotubule agents may work at least in part because of their antimitochondrial effect.

	ACKNOWLEDGMENTS

 
We thank the transmission electron microscopy department in the Faculty of Medicine (Université de la Mediterranée, Marseille, France) and Dr. Leslie Wilson for critical comments on the manuscript.

	FOOTNOTES

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ M. A. J. was supported by NIH Grant CA 57291.

² To whom requests for reprints should be addressed, at UPRESA Centre National de la Recherche Scientifique 6032, Universite de la Mediterranée, Faculty of Pharmacy, 27 Boulevard Jean Moulin, 13005 Marseille, France. Phone: 33491835635; Fax: 33491782024; E-mail: diane.braguer{at}pharmacie.univ-mrs.fr

³ The abbreviations used are: PTP, permeability transition pore; CsA, cyclosporin A; RR, respiration rate; VDAC, voltage-dependent anion channel.

Received 4/24/00. Accepted 8/16/00.

	REFERENCES

Top ABSTRACT Introduction Materials and Methods Results Discussion REFERENCES

 

1. Saraste M. Oxidative phosphorylation at the fin de siècle. Science (Washington DC), 283: 1488-1493, 1999.[Abstract/Free Full Text]
2. Green D. R., Reed J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.[Abstract/Free Full Text]
3. Kroemer G., Zamzani N., Susin S. A. Mitochondrial control of apoptosis. Immunol. Today, 18: 44-51, 1997.[Medline]
4. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiate an apoptotic protease cascade. Cell, 91: 479-489, 1997.[Medline]
5. Waterhouse N. J., Green D. R. Mitochondria and apoptosis: HQ or high-security prison?. J. Clin. Immunol., 19: 378-387, 1999.[Medline]
6. Vander Heiden M. G., Thompson C. B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?. Nat. Cell. Biol., 1: E209-E216, 1999.[Medline]
7. Eisenhauer E. A., Vermorken J. B. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs, 55: 5-30, 1998.[Medline]
8. Jordan M. A., Wilson L. The use and action of drugs in analyzing mitosis. Methods Cell Biol., 61: 267-295, 1999.[Medline]
9. Fan W. Possible mechanism of paclitaxel-induced apoptosis. Biochem. Pharmacol., 57: 1215-1221, 1999.[Medline]
10. Gonçalves, A., Braguer, D., Carles, G., André, N., Prevôt, C., and Briand, C. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29–D4). Biochem. Pharmacol., in press, 2000.
11. Fulda S., Susin S. A., Kroemer G., Debatin K. M. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res., 58: 4453-4460, 1998.[Abstract/Free Full Text]
12. Larochette N., Decaudin D., Jacotot E., Brenner C., Marzo I., Susin S. A., Zamzami N., Xie Z., Reed J., Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res., 249: 413-421, 1999.[Medline]
13. Ravagnan L., Marzo I., Costantini P., Susin S. A., Zamzami N., Petit P. X., Hirsch F., Goulbern M., Poupon M. F., Miccoli L., Xie Z., Reed J. C., Kroemer G. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene, 18: 2537-2546, 1999.[Medline]
14. Rigobello M. P., Scutari G., Friso A., Barzon E., Artusi S., Bindoli A. Mitochondrial permeability transition and release of cytochrome c induced by retinoic acids. Biochem. Pharmacol., 58: 665-670, 1999.[Medline]
15. Fulda S., Scaffidi C., Susin S. A., Krammer P. H., Kroemer G., Peters M. E., Debatin K. M. Activation of mitochondria and release of mitochondrial apoptogenic factor by betulinic acid. J. Biol. Chem., 273: 33942-33948, 1998.[Abstract/Free Full Text]
16. Guise S., Braguer D., Renacle-Bonnet M., Pommier G., Briand C. Tau protein is involved in the apoptotic process induced by antimicrotubule agents on neuroblastoma cells. Apoptosis, 4: 47-58, 1999.[Medline]
17. Lemesle-Meunier D., Chevillotte-Brivet P., Pajot P. Cytochrome b-565 in Saccharomyces cerevisiae: use of mutants in the cob-cox region of the mitochondrial DNA to study the functional role of this spectral species of cytochrome b. I. Measurement of cytochrome b-565 and selection of revertants devoid of cytochrome b-565. Eur. J. Biochem., 111: 151-159, 1980.[Medline]
18. Wang S., Wang Z., Boise L. H., Dent P., Grant S. Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-x_L. Leukemia (Baltimore), 13: 1564-1573, 1999.[Medline]
19. Carles G., Braguer D., Dumontet C., Bourgarel V., Goncalves A., Sarrazin M., Rognoni J. B., Briand C. Differentiation of human colon cancer cells changes the expression of ß-tubulin isotypes and MAPs. Br. J. Cancer, 80: 1162-1168, 1999.[Medline]
20. Kirsch D. G., Doseff A., Chau B. N., Lim D. S., De Souza-Pinto N. C., Hansford R., Kastan M. B., Lazebnik Y. A., Hardwick J. M. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem., 274: 21155-21161, 1999.[Abstract/Free Full Text]
21. Bernier-Valentin F., Aunis D., Rousset B. Evidence for tubulin-binding sites on cellular membranes: plasma membranes, mitochondrial membranes, and secretory granule membranes. J. Cell. Biol., 97: 209-216, 1983.[Abstract/Free Full Text]
22. Jordan M. A., Toso R. J., Thrower D., Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.[Abstract/Free Full Text]
23. Priault M., Chaudhuri B., Clow A., Camougrand N., Manon S. Investigation of bax-induced release of cytochrome c from yeast mitochondria. Eur. J. Biochem., 260: 684-691, 1999.[Medline]
24. Manzano A., Roig T., Bermudez J., Bartons R. Effects of Taxol on isolated rat hepatocyte metabolism. Am. J. Physiol., 271: 1957-1962, 1996.
25. Etvodienko Y. V., Teplova V. V., Sidash S. S., Ichas F., Mazat J. P. Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria. FEBS Lett., 393: 86-88, 1996.[Medline]
26. Malorni W., Meshini S., Matarrese P., Arancia G. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine. Anticancer Res., 12: 2037-2045, 1992.[Medline]
27. Li Y. M., Broome J. D. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res., 59: 776-780, 1999.[Abstract/Free Full Text]
28. Bouillet P., Metcalf D., Huang D. C. S., Tarlinton D. M., Kay T. W. H., Köntgen F., Adams J. M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic response, leucocyte homeostasis and to preclude autoimmunity. Science (Washington DC), 286: 1735-1741, 1999.[Abstract/Free Full Text]
29. Gupta R. S., Dudani A. K. Mechanism of action of antimitotic drugs: a new hypothesis based on the role of cellular calcium. Med. Hypotheses, 28: 57-69, 1989.[Medline]
30. Rodi D. J., Janes R. W., Sanganee H. J., Holton R. A., Wallace B. A., Makwski L. Screening of a library of phage-displayed peptides identifies human Bcl-2 as a Taxol-binding protein. J. Mol. Biol., 285: 197-203, 1999.[Medline]

This article has been cited by other articles:

				M.-A. Esteve, M. Carre, V. Bourgarel-Rey, A. Kruczynski, G. Raspaglio, C. Ferlini, and D. Braguer Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine. Mol. Cancer Ther., November 1, 2006; 5(11): 2824 - 2833. [Abstract] [Full Text] [PDF]

				S.-J. Park, C.-H. Wu, J. D. Gordon, X. Zhong, A. Emami, and A. R. Safa Taxol Induces Caspase-10-dependent Apoptosis J. Biol. Chem., December 3, 2004; 279(49): 51057 - 51067. [Abstract] [Full Text] [PDF]

				E. Pasquier, M. Carre, B. Pourroy, L. Camoin, O. Rebai, C. Briand, and D. Braguer Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway Mol. Cancer Ther., October 1, 2004; 3(10): 1301 - 1310. [Abstract] [Full Text] [PDF]

				B. Pourroy, M. Carre, S. Honore, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer Low Concentrations of Vinflunine Induce Apoptosis in Human SK-N-SH Neuroblastoma Cells through a Postmitotic G1 Arrest and a Mitochondrial Pathway Mol. Pharmacol., September 1, 2004; 66(3): 580 - 591. [Abstract] [Full Text] [PDF]

				C. Ferlini, G. Raspaglio, S. Mozzetti, M. Distefano, F. Filippetti, E. Martinelli, G. Ferrandina, D. Gallo, F. O. Ranelletti, and G. Scambia Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance Mol. Pharmacol., July 1, 2003; 64(1): 51 - 58. [Abstract] [Full Text] [PDF]

				A. Goncalves, F. Viret, J. Ciccolini, D. Genre, G. Gravis, M. Giovanini, J. Camerlo, J. Catalin, D. Maraninchi, and P. Viens Phase I and Pharmacokinetic Study of Escalating Dose of Docetaxel Administered with Granulocyte Colony-stimulating Factor Support in Adult Advanced Solid Tumors Clin. Cancer Res., January 1, 2003; 9(1): 102 - 108. [Abstract] [Full Text] [PDF]

				M. Carre, N. Andre, G. Carles, H. Borghi, L. Brichese, C. Briand, and D. Braguer Tubulin Is an Inherent Component of Mitochondrial Membranes That Interacts with the Voltage-dependent Anion Channel J. Biol. Chem., September 6, 2002; 277(37): 33664 - 33669. [Abstract] [Full Text] [PDF]

				J. F. Kidd, M. F. Pilkington, M. J. Schell, K. E. Fogarty, J. N. Skepper, C. W. Taylor, and P. Thorn Paclitaxel Affects Cytosolic Calcium Signals by Opening the Mitochondrial Permeability Transition Pore J. Biol. Chem., February 15, 2002; 277(8): 6504 - 6510. [Abstract] [Full Text] [PDF]

				J.-i. Okano and A. K. Rustgi Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery J. Biol. Chem., May 25, 2001; 276(22): 19555 - 19564. [Abstract] [Full Text] [PDF]

				X. Deng, L. Xiao, W. Lang, F. Gao, P. Ruvolo, and W. S. May Jr. Novel Role for JNK as a Stress-activated Bcl2 Kinase J. Biol. Chem., June 22, 2001; 276(26): 23681 - 23688. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by André, N. Articles by Briand, C. Search for Related Content PubMed PubMed Citation Articles by André, N. Articles by Briand, C.